Close
Digital Health & Ai Innovation summit 2026
APE 2026

PerkinElmer announces launch of NexION™ 300 ICP-MS

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Zoll Launches Next-Gen LifeVest Wearable in...

ZOLL, a medical device and related software solutions maker,...

EU Commission Proposes Reforms in Medical...

The European Commission has proposed targeted reforms that are...

New York Funds $300m to Modernize...

The state of New York plans to invest $300...

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced the launch of the NexION™ 300 Inductively Coupled Plasma-Mass Spectrometer (ICP-MS) for elemental analysis at PITTCON® 2010, March 1-4, 2010, Booth 2769.

“The NexION 300 platform advances trace element analysis, and its introduction is perfectly timed to help address global problems ranging from contamination of our air, water and food, to the integrity of pharmaceuticals and nutritional supplements, as well as the safety of emerging nanomaterials,” explained Martin Long, vice president, spectroscopy, Analytical Sciences and Laboratory Services, PerkinElmer.

He added, “Researchers can now benefit from a simplified system for analysis of trace elements in the parts-per-trillion range, allowing even non-expert users to perform complex analyses. The new NexION 300 system also greatly reduces the need for daily user maintenance and cleaning, translating into minimal downtime and less need for highly-skilled operators."
The NexION 300 instrument features the patented Universal Cell Technology™ (UCT) and is the only instrument of its kind with three modes of interference removal – Standard, Collision and Reaction. These three modes allow scientists to choose the appropriate technique for their particular application, based on the complexity of the problem to be solved.

NexION’s Standard mode can be used for simple and routine analyses. Collision mode is effective for semi-quantitative analyses, environmental sample monitoring and testing unknown samples. Reaction mode, using patented DRC™ technology, provides the best detection limits available, for even the most difficult elements and matrices such as semiconductor testing.

The NexION 300 system can be integrated with chromatography systems for effective speciation analysis to enable customers to accurately separate and measure the toxicity, bioavailability, metabolism and environmental mobility of elements.

Latest stories

Related stories

Zoll Launches Next-Gen LifeVest Wearable in the U.S.

ZOLL, a medical device and related software solutions maker,...

EU Commission Proposes Reforms in Medical Device Regulation

The European Commission has proposed targeted reforms that are...

New York Funds $300m to Modernize Hospital IT Infrastructure

The state of New York plans to invest $300...

RECTIFIER from AIwithCare of Mass General Brigham Launched

Mass General Brigham has revealed the development of an...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »